Status:
COMPLETED
The Application of Pectoral Nerve II(PECS II)block in Breast Fibroadenoma Resection Surgery
Lead Sponsor:
Inner Mongolia Baogang Hospital
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Patients were randomly assigned to the GA group, PECS II group, or TPVB group using a computer-generated random number table. Group assignments were kept in a sealed envelope, which was opened only af...
Detailed Description
Written informed consent was obtained from all participants.90 female patients aged 18 to 65 with ASA I-II status were selected at Baogang Hospital, Inner Mongolia, who had been diagnosed with breast ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of breast fibromas
Exclusion
- heart attack mental disorder
Key Trial Info
Start Date :
July 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06608810
Start Date
July 30 2023
End Date
June 1 2024
Last Update
September 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inner Mongolia Baogang Hospital
Baotou, Inner Mongolia, China, 014010